120. An open-label comparative trial of SUBA-itraconazole (SUBA) versus conventional itraconazole (c-itra) for treatment of proven and probable endemic mycoses (MSG-15): a pharmaco...

por Pappas, Peter G, Spec, Andrej, Miceli, Marisa, McGwin, Gerald, McMullen, Rachel, Thompson III, George R R
Publicado 2021

144. MSG-15: Pharmacokinetic (PK), Adverse Events (AEs), and Tolerability Data from an Open Label Randomized Clinical Trial (RCT) Comparing Oral Suba-itraconazole (SUBA-ITC) to Con...

por Pappas, Peter G, Spec, Andrej, Miceli, Marisa H, Proia, Laurie, Arauz, Ana Belen, Hayes, Justin, Peinhardt, Alisa, McMullen, Rachel, Moore, Mary K, McGwin, Gerald, Thompson III, George R
Publicado 2020